Inflammatory CD248+ activated fibroblasts are a potential therapeutic target in ischemic heart disease
Joel G. Rurik(Karolinska Institutet)
Cited by 0
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
Immune Cells and Immunotherapy for Cardiac Injury and Repair
|Circulation Research|2021|269
CAR-based therapies: opportunities for immuno-medicine beyond cancer
|Nature Metabolism|2022|122
Tissue-specific Grb10/Ddc insulator drives allelic architecture for cardiac development
|Molecular Cell|2022|33